arrow_back
BP601 | Medicinal Chemistry-III
BP601 | Front Pages & Table of Contents
BP601T Chapter-1 Antibiotics
BP601T Chapter-2 Macrolide, Prodrug & Antimalarial Drugs
BP601T Chapter-3 Antitubercular, Urinary Tract Anti-Infective & Antiviral agents
BP601T Chapter-4 Antifungal, Anti Protozoal, Antihelmintics, Sulphonamides & Sulfones, Folate Reductase Inhibitors
BP601T Chapter-5 Introduction to drug design & combinatorial chemistry
BP601T Index
BP602 | Pharmacology-III
BP602 | Front Pages & Table of Contents
BP602T Chapter-1 Anti-Asthmatic Drugs & Management of COPD
BP602T Chapter-2 Expectorant, Antitussives, Nasal Decongestants & Analeptics
BP602T Chapter-3 Anti-Ulcer Agents
BP602T Chapter-4 Drugs for Constipation and Diarrhea
BP602T Chapter-5 Appetite Stimulants & Suppressants, Digestants & Carminatives
BP602T Chapter-6 Emetics and Anti-Emetics
BP602T Chapter-7 General Principle of Chemotherapy
BP602T Chapter-8 Anti-Microbial Agents
BP602T Chapter-9 Antitubercular Agent
BP602T Chapter-10 Antileprotic Agents
BP602T Chapter-11 Anti-Viral Agents
BP602T Chapter-12 Antifungal Drugs
BP602T Chapter-13 Anthelmintic Drugs
BP602T Chapter-14 Antiprotozoal Agents
BP602T Chapter-15 Antimalarial agents
BP602T Chapter-16 Urinary Tract Infection & Sexually Transmitted Diseases
BP602T Chapter-17 Chemotherapy of Malignancy
BP602T Chapter-18 Immunopharmacology
BP602T Chapter-19 Principle of Toxicology
BP602T Index
BP603 | Herbal Drug Technology
BP603 | Front Pages & Table of Contents
BP603T Chapter-1 Herbs as raw material
BP603T Chapter-2 Biodynamic agriculture
BP603T Chapter-3 Indian systems of medicine
BP603T Chapter-4 Nutraceutical
BP603T Chapter-5 Herbal drug and herb-food interactions
BP603T Chapter-6 Herbal Cosmetics
BP603T Chapter-7 Herbal Excipients
BP603T Chapter-8 Herbal Formulations
BP603T Chapter-9 Evaluation of drugs who & ich guidelines
BP603T Chapter-10 Patenting & regulatory requirements of natural products
BP603T Chapter-11 Regulatory issues
BP603T Chapter-12 General introduction to herbal drug industry
BP603T Chapter-13 Schedule T – GMP of Indian systems of medicine
BP603T Index
BP604 | Biopharmaceutics & Pharmacokinetics
BP604 | Front Pages & Table of Contents
BP604T Chapter-1 Absorption and Distribution
BP604T Chapter-2 Elimination, Bioavailability and bioequivalence
BP604T Chapter-3 Pharmacokinetics
BP604T Chapter-4 Multicompartment Models
BP604T Chapter-5 Non-Linear Pharmacokinetics
BP604T Index
BP605 | Pharmaceutical Biotechnology
BP605 | Front Pages & Table of Contents
BP605T Chapter-1 Introduction to Biotechnology
BP605T Chapter-2 Enzyme Biotechnology
BP605T Chapter-3 Biosensor
BP605T Chapter-4 Protein engineering & Genetic engineering
BP605T Chapter-5 Microbes and Enzymes
BP605T Chapter-6 Cloning Vector, Restriction Endonuclease & DNA Ligase
BP605T Chapter-7 Recombinant DNA Technology
BP605T Chapter-8 Polymerase Chain Reaction
BP605T Chapter-9 Immunity
BP605T Chapter-10 Immune Blotting Techniques
BP605T Chapter-11 Prokaryotes and Eukaryotes
BP605T Chapter-12 Microbial Genetics and Biotransformation
BP605T Chapter-13 Mutation
BP605T Chapter-14 Fermentation
BP605T Index
BP606 | Pharm. Quality Assurance
BP606 | Front Pages & Table of Contents
BP606T Chapter-1 Quality Assurance and Quality Management Concept
BP606T Chapter-2 Total Quality Management
BP606T Chapter-3 ICH Guidelines
BP606T Chapter-4 Quality by design (QbD)
BP606T Chapter-5 ISO 9000 & ISO 14000
BP606T Chapter-6 NABL Accreditation
BP606T Chapter-7 Organization and personnel
BP606T Chapter-8 Premises
BP606T Chapter-9 Equipment’s and Raw materials
BP606T Chapter-10 Quality Control
BP606T Chapter-11 Good Laboratory Practices
BP606T Chapter-12 Complaints
BP606T Chapter-13 Document maintenance in pharmaceutical industry
BP606T Chapter-14 Calibration and Validation
BP606T Chapter-15 Warehousing
BP606T Index